NCT02166567

Brief Summary

In assisted reproductive technology (ART) semen needs to be processed. Commonly used methods rely on physical properties of the spermatozoa, such as the swim-up methods and density gradient centrifugation. It is now known that current processing of spermatozoa does not prevent the admixture of spermatozoa with damaged genetic material. The latter have a negative impact on the outcome of ART. The investigators developed a new method for the processing of spermatozoa with intact genetic material based on flow cytometry and sorting (FACS) and on staining using a deye, YoPro. The investigators aim at examining the effect of this novel method of sperm sorting on the outcome of ART.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 14, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 18, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

December 12, 2017

Status Verified

December 1, 2017

Enrollment Period

3.7 years

First QC Date

June 14, 2014

Last Update Submit

December 11, 2017

Conditions

Keywords

intracytoplasmic sperm injectionMale infertilityapoptosisflow cytometry and sortingDNA fragmentation

Outcome Measures

Primary Outcomes (1)

  • Ongoing pregnancy rate

    Week 12 of gestation

Secondary Outcomes (1)

  • Number of diploidic fertilized oocytes.

    one day after intracytoplasmic sperm injection

Other Outcomes (2)

  • Number of embryos growing to the blastocyst stage

    5 days after intracytoplasmic sperm injection

  • Implantation rate, e.g. number of implanted embryos with heart activity per number of embryos transferred

    week 12 of gestation

Study Arms (2)

YoPro and FACS

EXPERIMENTAL

Spermatozoa to be used for ICSI will be stained with the YoPro Dye and then be sorted with FACS to select non-YoPro stained spermatozoa, known to have significantly less fragmented DNA.

Procedure: Staining of spermatozoa with the YoPro dye and sorting of the stained spermatozoa with FACS

Swim-up

ACTIVE COMPARATOR

Spermatozoa will be processed using the conventional swim-up me

Procedure: Swim-up

Interventions

Swim-upPROCEDURE

Semen processing will be carried out with the conventional swim-up method.

Swim-up

Eligibility Criteria

Age22 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • infertile couples needing treatment with ICSI
  • male infertility as defined by the WHO 2010 criteria
  • age of the treated women should be between 22 and 39 years of age.
  • normal ovarian reserve, as defined by basal FSH-concentration below 10 IU/l and AMH-concentration above 10 pmol/l.
  • signed consent form.

You may not qualify if:

  • normal male infertility, as defined by the WHO 2010 criteria
  • age of the treated women below 22 years and above 39 years
  • reduced ovarian reserve, as defined by an elevated basal FSH-concentration or reduced AMH-concentration.
  • Not more than two preceding unsuccessfull treatments with ICSI
  • Severe disease of the male or female partner, such as HIV, hepatitis, or psychiatric illness.
  • Participation in another study.
  • lack of a signed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Basel

Basel, Basel BS, CH-4031, Switzerland

Location

Related Publications (2)

  • Ribeiro SC, Sartorius G, Pletscher F, de Geyter M, Zhang H, de Geyter C. Isolation of spermatozoa with low levels of fragmented DNA with the use of flow cytometry and sorting. Fertil Steril. 2013 Sep;100(3):686-94. doi: 10.1016/j.fertnstert.2013.05.030. Epub 2013 Jun 27.

    PMID: 23809499BACKGROUND
  • De Geyter C, Gobrecht-Keller U, Ahler A, Fischer M. Removal of DNA-fragmented spermatozoa using flow cytometry and sorting does not improve the outcome of intracytoplasmic sperm injection. J Assist Reprod Genet. 2019 Oct;36(10):2079-2086. doi: 10.1007/s10815-019-01571-1. Epub 2019 Aug 28.

MeSH Terms

Conditions

Infertility, Male

Interventions

Flow Cytometry

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Cell SeparationCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisCytophotometryFluorometryLuminescent MeasurementsPhotometryChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Christian De Geyter, MD, Prof.

    Univeristy Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2014

First Posted

June 18, 2014

Study Start

May 1, 2013

Primary Completion

January 1, 2017

Study Completion

November 1, 2017

Last Updated

December 12, 2017

Record last verified: 2017-12

Locations